| Product Code: ETC11389237 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Anticoagulants Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Anticoagulants Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Anticoagulants Market - Industry Life Cycle |
3.4 Latvia Anticoagulants Market - Porter's Five Forces |
3.5 Latvia Anticoagulants Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Latvia Anticoagulants Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Latvia Anticoagulants Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Latvia Anticoagulants Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Latvia |
4.2.2 Growing geriatric population leading to higher demand for anticoagulants |
4.2.3 Advancements in healthcare infrastructure and access to medical facilities |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of anticoagulant drugs |
4.3.2 High costs associated with anticoagulant therapy |
4.3.3 Limited awareness about anticoagulant therapy among patients and healthcare professionals |
5 Latvia Anticoagulants Market Trends |
6 Latvia Anticoagulants Market, By Types |
6.1 Latvia Anticoagulants Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Anticoagulants Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Latvia Anticoagulants Market Revenues & Volume, By Direct Oral Anticoagulants, 2021 - 2031F |
6.1.4 Latvia Anticoagulants Market Revenues & Volume, By Vitamin K Antagonists, 2021 - 2031F |
6.1.5 Latvia Anticoagulants Market Revenues & Volume, By Heparin, 2021 - 2031F |
6.2 Latvia Anticoagulants Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Latvia Anticoagulants Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Latvia Anticoagulants Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 Latvia Anticoagulants Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Latvia Anticoagulants Market Revenues & Volume, By Deep Vein Thrombosis, 2021 - 2031F |
6.3.3 Latvia Anticoagulants Market Revenues & Volume, By Atrial Fibrillation, 2021 - 2031F |
6.3.4 Latvia Anticoagulants Market Revenues & Volume, By Pulmonary Embolism, 2021 - 2031F |
7 Latvia Anticoagulants Market Import-Export Trade Statistics |
7.1 Latvia Anticoagulants Market Export to Major Countries |
7.2 Latvia Anticoagulants Market Imports from Major Countries |
8 Latvia Anticoagulants Market Key Performance Indicators |
8.1 Number of patients prescribed anticoagulants |
8.2 Compliance rate of patients with anticoagulant therapy |
8.3 Number of healthcare facilities offering anticoagulant treatments |
9 Latvia Anticoagulants Market - Opportunity Assessment |
9.1 Latvia Anticoagulants Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Latvia Anticoagulants Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Latvia Anticoagulants Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Latvia Anticoagulants Market - Competitive Landscape |
10.1 Latvia Anticoagulants Market Revenue Share, By Companies, 2024 |
10.2 Latvia Anticoagulants Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here